Supreme Court dismisses case against FDA approval of abortion drug regimen

The chapter explores a group's legal challenge against the FDA's approval of a two-pill abortion drug regimen and how the Supreme Court ultimately dismissed the case due to lack of direct injury to doctors. The discussion also covers the implications of this decision on abortion regulations, the challenges faced by pro-life organizations, and the ongoing efforts to support pregnancy resource centers amidst changing legal landscapes and cultural attitudes surrounding abortion.